Joong‐Won Park

Researcher Next ID · RN-005695

Researcher · Medicine

Goyang-si, South Korea

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Hepatocellular Carcinoma Treatment and Prognosis

Liver Disease Diagnosis and Treatment

Cancer Genomics and Diagnostics

Cholangiocarcinoma and Gallbladder Cancer Studies

Hepatitis B Virus Studies

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)30207-1
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1717002
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Liver International · 2015 · https://doi.org/10.1111/liv.12818
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Journal of Hepatology · 2014 · https://doi.org/10.1016/j.jhep.2014.01.021
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2012.48.4410

No projects listed.